These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 29106542)

  • 1. Dopamine System Dysregulation in Major Depressive Disorders.
    Belujon P; Grace AA
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):1036-1046. PubMed ID: 29106542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential roles for opioid receptors in motivation and major depressive disorder.
    Callaghan CK; Rouine J; O'Mara SM
    Prog Brain Res; 2018; 239():89-119. PubMed ID: 30314570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of brain dopamine systems in major depressive disorder.
    Delva NC; Stanwood GD
    Exp Biol Med (Maywood); 2021 May; 246(9):1084-1093. PubMed ID: 33593109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression, anhedonia, and psychomotor symptoms: the role of dopaminergic neurocircuitry.
    Stein DJ
    CNS Spectr; 2008 Jul; 13(7):561-5. PubMed ID: 18622360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
    Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Proinflammatory Cytokines in Dopaminergic System Disturbances, Implications for Anhedonic Features of MDD.
    Pan Z; Rosenblat JD; Swardfager W; McIntyre RS
    Curr Pharm Des; 2017; 23(14):2065-2072. PubMed ID: 28078987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder.
    Swardfager W; Herrmann N; McIntyre RS; Mazereeuw G; Goldberger K; Cha DS; Schwartz Y; Lanctôt KL
    Neurosci Biobehav Rev; 2013 Jun; 37(5):911-29. PubMed ID: 23567517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.
    Reynolds LM; Reynolds GP
    J Psychiatr Res; 2011 Jan; 45(1):54-9. PubMed ID: 20684832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of dopamine system responsivity and its adaptive and pathological response to stress.
    Belujon P; Grace AA
    Proc Biol Sci; 2015 Apr; 282(1805):. PubMed ID: 25788601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain membrane lipids in major depression and anxiety disorders.
    Müller CP; Reichel M; Mühle C; Rhein C; Gulbins E; Kornhuber J
    Biochim Biophys Acta; 2015 Aug; 1851(8):1052-65. PubMed ID: 25542508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic-based pharmacotherapies for depression.
    Papakostas GI
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity.
    Huang YJ; Lane HY; Lin CH
    Neural Plast; 2017; 2017():4605971. PubMed ID: 28491480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen, stress and the brain: progress toward unraveling gender discrepancies in major depressive disorder.
    Shansky RM
    Expert Rev Neurother; 2009 Jul; 9(7):967-73. PubMed ID: 19589047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine, magnesium and major depression--from pharmacology to pathophysiology and back.
    Murck H
    J Psychiatr Res; 2013 Jul; 47(7):955-65. PubMed ID: 23541145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-anhedonic effect of deep brain stimulation of the prefrontal cortex and the dopaminergic reward system in a genetic rat model of depression: an intracranial self-stimulation paradigm study.
    Rea E; Rummel J; Schmidt TT; Hadar R; Heinz A; Mathé AA; Winter C
    Brain Stimul; 2014; 7(1):21-8. PubMed ID: 24139146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic mechanisms of target detection - P300 event related potential and striatal dopamine.
    Pogarell O; Padberg F; Karch S; Segmiller F; Juckel G; Mulert C; Hegerl U; Tatsch K; Koch W
    Psychiatry Res; 2011 Dec; 194(3):212-218. PubMed ID: 22104371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of hippocampal deactivation during loss events in treatment-resistant depression.
    Johnston BA; Tolomeo S; Gradin V; Christmas D; Matthews K; Steele JD
    Brain; 2015 Sep; 138(Pt 9):2766-76. PubMed ID: 26133661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The positive effect on ketamine as a priming adjuvant in antidepressant treatment.
    Melo A; Kokras N; Dalla C; Ferreira C; Ventura-Silva AP; Sousa N; Pêgo JM
    Transl Psychiatry; 2015 May; 5(5):e573. PubMed ID: 26080090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the neurobiological mechanisms of major depressive disorders.
    Fakhoury M
    Gen Hosp Psychiatry; 2015; 37(2):172-7. PubMed ID: 25772946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.